Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
基本信息
- 批准号:10706327
- 负责人:
- 金额:$ 8.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdolescenceAflatoxin B1AflatoxinsAfricaAfrica South of the SaharaAfricanAnimal FeedAreaAspergillusBindingBiological ProductsBirthBloodBlood specimenBreast FeedingCancer EtiologyCarcinogensCessation of lifeChemical AgentsChildCountryCytochrome P450DNADNA MethylationDataDevelopmentDiagnosisDiseaseDisease susceptibilityEnvironmentEnvironmental ExposureEnvironmental PollutantsEnzymesEpigenetic ProcessExposure toFirst Pregnancy TrimesterFoodFood ContaminationGene ExpressionGene Expression ProfilingGoalsGrainHepatotoxicityHeritabilityHigh Pressure Liquid ChromatographyHospitalsHumanIncidenceLifeLinkLiverLysineMalignant NeoplasmsMalignant neoplasm of liverMembraneMethylationModificationMoldsMolecularMothersMutationNewborn InfantNigeriaNigerianNucleic AcidsNutrientOnset of illnessOrganPlacentaPlasmaPlayPoisonPolymerase Chain ReactionPopulationPredispositionPregnancyPregnant WomenPrimary carcinoma of the liver cellsProcessPublic HealthRNARegulationResearchResearch PersonnelRiskRodentRoleRouteRuralTestingThird Pregnancy TrimesterTimeToxic Environmental SubstancesTumor Suppressor GenesUmbilical Cord BloodWeaningWomanadductbisulfitecarcinogenesiscohortearly childhoodearly experienceearly life exposureearly onsetepigenetic markerepigenomein uteroinfancyinsightliver developmentprenatal exposurepyrosequencingrecruiturban area
项目摘要
Project Summary
Aflatoxin B1 (AFB1) is a major cause of hepatocellular carcinoma (HCC) in Sub Saharan Africa, where
aflatoxin contamination is common. In these areas, exposure to AFB1 starts early in life through maternal
routes during pregnancy. Populations in these countries experience early onset of HCC, and in utero AFB1
exposure may be a contributing factor to the onset of the disease. Exposures to nutrients, toxic chemicals and
biological agents during gestation and early childhood play a critical role in determining susceptibility to
diseases later in life. The mechanism of early onset of carcinogenesis may include epigenetic changes in
tumor suppressor genes (TSGs). Our previous rodent study showed that in utero AFB1 exposure can alter
DNA methylation of TSGs. It is necessary to investigate the impact of in utero AFB1 exposure on methylation
and expression of TSGs in humans. The overall hypothesis is that in utero AFB1 exposure will differentially
methylate TSGs, and this methylation will inversely correlate with the expression of the TSGs. The overall
objective of this project is to establish a pre-birth cohort and study the association between in utero exposure
to AFB1 and DNA methylation changes in TSGs of newborns in Nigeria. To achieve this, we will recruit
pregnant women in the first trimester from two Nigerian hospitals serving a rural and an urban area. We
hypothesize that Nigerian women will have a range of AFB1 exposure levels detectable in plasma. We
hypothesize that in utero AFB1 exposure will be associated with differential methylation and expression of
TSGs in cord blood samples. The specific aims of this project are to 1) determine the levels of AFB1 in the
plasma of pregnant women, using HPLC, collected during the first and third trimesters of pregnancy, and
newborns (cord blood), 2) assess the DNA methylation of TSGs in the cord blood via pyrosequencing and to
determine if AFB1 concentration is associated with the levels of DNA methylation, 3) determine the expression
of TSGs in the cord blood using real-time quantitative PCR and determine if gene expression is inversely
correlated with methylation changes in the TSGs. The findings of this study will provide data on AFB1
exposure among pregnant women in Nigeria and its subsequent effect on the epigenome of newborns. This
data will provide direction for future research developing epigenetic biomarkers of AFB1 exposure as well as
investigating epigenetic mechanisms associated with prenatal exposure to AFB1 and the risk of developing
liver cancer in Africa. This research direction may provide insight into reducing the incidence of this cancer in
sub-Saharan Africa, especially in countries such as Nigeria, where AFB1 exposure is highly prevalent. Through
this research, the PI will become a leader in environmental epigenetics, studying how early-life exposure to
environmental contaminants of Public Health concerns in Africa contributes to the development of non-
communicable diseases later in life.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Oluwakemi Anuoluwapo Rotimi其他文献
Oluwakemi Anuoluwapo Rotimi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Oluwakemi Anuoluwapo Rotimi', 18)}}的其他基金
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10518414 - 财政年份:2022
- 资助金额:
$ 8.68万 - 项目类别:
相似海外基金
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10518414 - 财政年份:2022
- 资助金额:
$ 8.68万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8827703 - 财政年份:2012
- 资助金额:
$ 8.68万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
9031727 - 财政年份:2012
- 资助金额:
$ 8.68万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8629710 - 财政年份:2012
- 资助金额:
$ 8.68万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8293559 - 财政年份:2012
- 资助金额:
$ 8.68万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8464677 - 财政年份:2012
- 资助金额:
$ 8.68万 - 项目类别:
Monoclonal antibody-based electronic immunosensor for the determination of aflatoxin B1
基于单克隆抗体的电子免疫传感器测定黄曲霉毒素B1
- 批准号:
412237-2010 - 财政年份:2011
- 资助金额:
$ 8.68万 - 项目类别:
Engage Grants Program
Increased Nucleotide Excision Repair Activity of Aflatoxin-B1-N7-Guanine Adducts but not Aflatoxin-B1-Formamidopyrimidine Adducts in Livers of Mice Exposed Chronically to Aflatoxin-B1
长期暴露于黄曲霉毒素-B1 的小鼠肝脏中黄曲霉毒素-B1-N7-鸟嘌呤加合物的核苷酸切除修复活性增加,但黄曲霉毒素-B1-甲酰胺嘧啶加合物的核苷酸切除修复活性不增加
- 批准号:
240887 - 财政年份:2011
- 资助金额:
$ 8.68万 - 项目类别:
Modulation of Aflatoxin B1-induced hepatocarcinogenesis by RB loss
通过 RB 损失调节黄曲霉毒素 B1 诱导的肝癌发生
- 批准号:
7225591 - 财政年份:2006
- 资助金额:
$ 8.68万 - 项目类别:
Modulation of Aflatoxin B1-induced hepatocarcinogenesis by RB loss
通过 RB 损失调节黄曲霉毒素 B1 诱导的肝癌发生
- 批准号:
7558390 - 财政年份:2006
- 资助金额:
$ 8.68万 - 项目类别:














{{item.name}}会员




